Summing Up Clinical Trials in Rare Diseases and Oncology Europe 

More on this topic:

We wrapped up the 2025 conference year in Munich at Clinical Trials in Rare Diseases and Clinical Trials in Oncology Europe. Thank you to all sponsors, delegations, and exhibitors for stopping by our booth and for the inspiring conversations throughout the event. 

Participants highlighted several noteworthy panel discussions, including the practical use of AI in clinical oncology trials, patient retention strategies, and the rapidly developing clinical research landscape in South America. We will cover some of these topics soon on our blog and share them first via our clinical trials newsletter

Thank you as well to our neighbours from Medidata Solutions, QPS Holdings, LLC, and TD2 Oncology. Congratulations to the prize winners: Petra Fettes (CatalYm GmbH) and Sumaiah Farook (Formycon AG)

Conference recap video: 

We will soon announce our 2026 conference calendar, which you can find here: Clinical research conference calendar

If you missed us in Munich, here’s a short recap – and we’re happy to connect anytime. 

See you soon! 

MICS Newsletter

Enjoyed the article?

Get insights once a month - straight to your inbox.